🇫🇷 France Country × Condition
multiple myeloma Clinical Trials in France
Active clinical trials for multiple myeloma with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇫🇷 France
Active Trials in France (4)
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Enrollment
135 pts
Country
🇫🇷 France
AbbVie
View Trial → NCT05137054 Phase 1
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Enrollment
317 pts
Country
🇫🇷 France
Regeneron Pharmaceuticals
View Trial → NCT07227311 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Enrollment
200 pts
Country
🇫🇷 France
GlaxoSmithKline
View Trial → NCT04888039
Recruiting
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
Enrollment
2,000 pts
Country
🇫🇷 France
University Hospital, Toulouse
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in France?
There are currently 4 active clinical trials for multiple myeloma with sites in France, of which 4 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in France?
To join a multiple myeloma clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in France?
Active multiple myeloma trials in France span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology